臺灣次世代基因定序檢測實作指引
1.0.0 - STU1.0.0

This page is part of the 臺灣次世代基因定序檢測實作指引 (v1.0.0: STU1.0.0) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

: Lung adenocarcinoma - XML Representation

Raw xml | Download


<Condition xmlns="http://hl7.org/fhir">
  <id value="con-lung-min"/>
  <meta>
    <profile
             value="https://nhicore.nhi.gov.tw/ngs/StructureDefinition/Condition-twngs"/>
  </meta>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-Condition-twngs.html">基因定序檢測報告之疾病資訊-Condition TWNGS</a></p></div><p><b>臨床狀態</b>：Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki">( <a href="http://terminology.hl7.org/CodeSystem/condition-clinical">ConditionClinicalStatusCodes</a>#active)</span></p><p><b>驗證狀態</b>：Confirmed <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki">( <a href="http://terminology.hl7.org/CodeSystem/condition-ver-status">ConditionVerificationStatus</a>#confirmed)</span></p><p><b>病情、問題或診斷分類</b>：Encounter Diagnosis <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki">( <a href="http://terminology.hl7.org/CodeSystem/condition-category">Condition Category Codes</a>#encounter-diagnosis)</span></p><p><b>病情、問題或診斷識別</b>：右側支氣管或肺惡性腫瘤 <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki">( <a href="https://twcore.mohw.gov.tw/ig/twcore/CodeSystem/icd-10-cm-2023-tw">臺灣2023年中文版ICD-10-CM</a>#C34.91)</span></p><p><b>病人</b>：<a href="Patient-pat-min.html">Patient/pat-min</a></p><p><b>診斷日期</b>：2024-07-10</p><p><b>申請理由</b>：完整 Foundation Medicine 檢測報告請看報告查詢系統中”分子病理室檢查報告之附件”，其內容包含腫瘤的基因突變、腫瘤突變負荷(TMB)、微衛星體不穩定性(MSI)相關資訊，並針對病患接受癌症標靶治療或免疫治療提供建議</p></div>
  </text>
  <clinicalStatus>
    <coding>
      <system
              value="http://terminology.hl7.org/CodeSystem/condition-clinical"/>
      <code value="active"/>
    </coding>
  </clinicalStatus>
  <category>
    <coding>
      <system
              value="http://terminology.hl7.org/CodeSystem/condition-category"/>
      <code value="encounter-diagnosis"/>
    </coding>
  </category>
  <code>
    <coding>
      <system
              value="https://twcore.mohw.gov.tw/ig/twcore/CodeSystem/icd-10-cm-2023-tw"/>
      <code value="C34.91"/>
      <display value="右側支氣管或肺惡性腫瘤"/>
    </coding>
  </code>
  <subject>🔗 
    <reference value="Patient/pat-min"/>
  </subject>
  <recordedDate value="2024-07-10"/>
  <note>
    <text
          value="完整 Foundation Medicine 檢測報告請看報告查詢系統中”分子病理室檢查報告之附件”，其內容包含腫瘤的基因突變、腫瘤突變負荷(TMB)、微衛星體不穩定性(MSI)相關資訊，並針對病患接受癌症標靶治療或免疫治療提供建議"/>
  </note>
</Condition>